Júlio César Teixeira

Author

Universidade Estadual de Campinas (UNICAMP)ORCID

Also Known As

F Struyf, J Teixeira, J. C. TEIXEIRA, J. C. Teixeira, J. Teixeira, J.C. Teixeira, Josiel Ramom Alves Teixeira, Juliana Vitória Moreira Teixeira, Julio C Teixeira, Julio C. Teixeira

157

Publications

Citations

H-Index

Concepts

All Affiliations

Universidade Estadual de Campinas (UNICAMP)Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre GlaxoSmithKline (United States)GlaxoSmithKline (Belgium)

About

Júlio César Teixeira is an author at Universidade Estadual de Campinas (UNICAMP) specializing in medicine, human papillomavirus vaccines, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	3.7K
2	Public Health	10	10	1.8K
3	Epidemiology	9	9	1.1K
4	Gastroenterology	2	2	76
5	Global Health	1	1	31

Júlio César Teixeira

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler, The Lancet VaccinationVaccine SafetyVaccine DevelopmentHuman Papillomavirus VaccinesVirology	2004	1.6K
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Matti Lehtinen, Jorma Paavonen, Cosette M. Wheeler, The Lancet Oncology VaccinationCervical Cancer ScreeningHpv-16/18 As04-adjuvanted VaccineCervical CancerCervical Health	2011	693
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Cosette M. Wheeler, Xavier Castellsagué, Suzanne M. Garland, The Lancet Oncology VaccinationVaccine SafetyCervical Cancer ScreeningPreventive MedicineCervical Cancer	2011	499
Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler, Obstetrical & Gynecological Survey ImmunologyGynecologyHpv InfectionVaccine HesitancyCervical Cancer Prevention	2005	247
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho, Human Vaccines & Immunotherapeutics	2014	245
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study Unnop Jaisamrarn, Xavier Castellsagué, Suzanne M. Garland, PLoS ONE	2013	206
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine Cecília Roteli-Martins, Paulo Naud, P. De Borba, Human Vaccines & Immunotherapeutics	2012	188
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women N. De Carvalho, Júlio César Teixeira, Cecília Roteli-Martins, Vaccine VaccinologyVaccine SafetyVaccinationHpv-16/18 As04-adjuvanted VaccineCervical Cancer	2010	169
Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18 Anne Szarewski, W.A.J. Poppe, S. Rachel Skinner, International Journal of Cancer Previous ExposureGynecologyCervical Cancer PreventionCancer-associated VirusHuman Papillomavirus Vaccines	2011	138
Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial Dan Apter, Cosette M. Wheeler, Jorma Paavonen, Clinical and Vaccine Immunology	2015	118

Page 1